FDA approved the first gene therapy for hereditary deafness https://ymaho.com/fda-approved-the-first-gene-therapy-for-hereditary-deafness
Regeneron's Otarmeni restores hearing to normal in 42% of patients. The therapy treats OTOF gene mutations with a single injection. Learn how AAV vector technology has for the first time restored the ability to hear a whisper.
REVERT cancer therapy: a new concept or a marketing gimmick? https://ymaho.com/revert-cancer-therapy-a-new-concept-or-a-marketing-gimmick
Analysis of the REVERT platform from KAIST: why turning cancer cells into normal cells is not news, but a PR tool. Read expert analysis and forecasts.
Yield on 10-year US Treasury bonds reached 4.5% https://ymaho.com/yield-on-10-year-us-treasury-bonds-reached-4-5
Analysis of the decline in Treasury prices: why 4.5% is the new normal, how it affects investors and the economy. Read details and forecasts.